Cidara Therapeutics, Inc. (CDTX)
219.60
-0.69
(-0.31%)
USD |
NASDAQ |
Dec 10, 16:00
219.75
+0.15
(+0.07%)
After-Hours: 20:00
Cidara Therapeutics Total Liabilities (Quarterly): 96.26M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 77.64B |
| Bristol Myers Squibb Co. | 78.29B |
| Johnson & Johnson | 113.54B |
| Mersana Therapeutics, Inc. | 122.22M |
| Pfizer Inc. | 115.64B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 518.65M |
| Shareholders Equity (Quarterly) | 422.39M |
| Debt to Equity Ratio | 0.0047 |
| Current Ratio | 4.620 |
| Net Debt Paydown Yield | 0.02% |